Login / Signup

Utility and optimal management of planned drug holidays during lenvatinib treatment in patients with unresectable differentiated thyroid cancer: a real-world multi-center study.

Takuya MikoshibaMariko SekimizuTakeyuki KonoRyoto NagaiTaiji KawasakiYoichiro SatoFumihiro ItoNana NakaharaSeiji ShigetomiHiroyuki Ozawa
Published in: Endocrine (2024)
Our results suggest that PDHs may extend OS, PFS, and TTF. In patients with PDH, various schedules used for lenvatinib administration highlight the difficulty in determining a uniform administration schedule. Therefore, it is crucial to consider the optimal lenvatinib administration schedule on a case-by-case basis.
Keyphrases
  • squamous cell carcinoma
  • emergency department
  • locally advanced
  • adverse drug
  • drug induced
  • smoking cessation